Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTSH vs MRNA✓SelectedUSD · MRNACTSH vs MRNA performance historyLatest closeAs of-1.14%11/16
Stock and ETF performance explorer

CTSH vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4.0%
MRNA return
+878.5%
Excess return
-874.5%
Maximum drawdown
-56.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.1%-3.6%+2.5%-1.0%
7D-1.6%-20.0%+18.4%-0.7%
30D-5.2%-1.3%-3.9%-5.4%
3M+7.1%+240.0%-232.8%-1.7%
6M+34.6%+339.0%-304.4%+21.4%
YTD-23.2%+630.0%-653.2%-32.9%
1Y-11.8%+769.1%-780.9%-23.7%
3Y-3.5%+181.2%-184.7%-13.5%
5Y-16.6%-8.1%-8.4%-23.8%
All+4.0%+878.5%-874.5%-6.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling